+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 20Years - 80Years
All Genders
ID03919461

Phase II Trial of Propranolol and Etodolac to Prevent Recurrence After Curative Surgery for Colon and Rectal Cancer

Led by Assaf-Harofeh Medical Center · Updated on 2019-04-18

200

Participants Needed

6

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying colorectal cancer patients undergoing surgery to see if using two drugs together around the time of surgery can reduce cancer spread and improve survival. The study focuses on how stress-related chemicals released during the perioperative period may promote cancer progression and tests whether blocking these chemicals with propranolol and etodolac can have anti-metastatic effects. The trial is a Phase II, double-blind, placebo-controlled study involving 200 patients. Participants will take propranolol and etodolac orally for 20 days, starting five days before surgery. The propranolol dose changes over time, starting lower before surgery, increasing on surgery day, and tapering afterward. Etodolac is given consistently twice daily during the entire period. There is also a placebo group following the same schedule. The study compares the effects of the drug combination versus placebo in preventing cancer recurrence. During the trial, patients will be monitored for survival outcomes over five years, including disease-free survival and overall survival. Biological markers in tumor tissue and blood will be assessed about one year after surgery to understand anti- and pro-metastatic processes. Safety will be tracked through adverse events within 30 days post-surgery, and psychological health, including depression and fatigue, will also be evaluated before and after surgery. The total follow-up time extends to five years.

CONDITIONS

Brief Title

Colorectal Metastasis Prevention International Trial 2

Research Team

O

Oded Zmora, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here